Suvretta Capital Management Holding in Alibaba Group Hldg LTD (BABA) Decreased by $64.01 Million; Bioscrip (BIOS) Stock Rose While Coliseum Capital Management Has Cut Stake by $7.47 Million

February 15, 2018 - By Peter Erickson

Aaron Cowen decreased its stake in Alibaba Group Hldg Ltd (BABA) by 16.91% based on its latest 2017Q3 regulatory filing with the SEC. Suvretta Capital Management Llc sold 372,160 shares as the company’s stock rose 22.58% with the market. The hedge fund run by Aaron Cowen held 1.83M shares of the business services company at the end of 2017Q3, valued at $315.88 million, down from 2.20M at the end of the previous reported quarter. Suvretta Capital Management Llc who had been investing in Alibaba Group Hldg Ltd for a number of months, seems to be less bullish one the $480.76 billion market cap company. The stock increased 0.33% or $0.61 during the last trading session, reaching $187.37. About 12.91 million shares traded. Alibaba Group Holding Limited (NYSE:BABA) has risen 57.33% since February 15, 2017 and is uptrending. It has outperformed by 40.63% the S&P500.

Christopher Shackelton decreased its stake in Bioscrip Inc (BIOS) by 66.4% based on its latest 2017Q3 regulatory filing with the SEC. Coliseum Capital Management Llc sold 3.73M shares as the company’s stock rose 8.97% with the market. The hedge fund run by Christopher Shackelton held 1.89M shares of the health care company at the end of 2017Q3, valued at $5.20M, down from 5.62M at the end of the previous reported quarter. Coliseum Capital Management Llc who had been investing in Bioscrip Inc for a number of months, seems to be less bullish one the $373.62 million market cap company. The stock increased 1.38% or $0.04 during the last trading session, reaching $2.93. About 496,823 shares traded. BioScrip, Inc. (NASDAQ:BIOS) has declined 29.17% since February 15, 2017 and is downtrending. It has underperformed by 45.87% the S&P500.

Among 6 analysts covering BioScrip (NASDAQ:BIOS), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. BioScrip had 13 analyst reports since August 11, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, August 11 by SunTrust. The rating was maintained by Jefferies on Thursday, June 8 with “Buy”. The firm has “Buy” rating given on Tuesday, July 25 by Jefferies. Jefferies maintained it with “Buy” rating and $4.0 target in Thursday, November 2 report. Dougherty & Company maintained the shares of BIOS in report on Wednesday, August 12 with “Buy” rating. The company was initiated on Tuesday, January 3 by Lake Street. On Wednesday, December 20 the stock rating was maintained by SunTrust with “Buy”. The stock of BioScrip, Inc. (NASDAQ:BIOS) earned “Buy” rating by Jefferies on Wednesday, August 9. As per Thursday, August 10, the company rating was upgraded by SunTrust. SunTrust maintained the shares of BIOS in report on Thursday, November 2 with “Buy” rating.

Analysts await BioScrip, Inc. (NASDAQ:BIOS) to report earnings on March, 2. They expect $-0.08 EPS, 0.00% or $0.00 from last year’s $-0.08 per share. After $-0.12 actual EPS reported by BioScrip, Inc. for the previous quarter, Wall Street now forecasts -33.33% EPS growth.

Investors sentiment decreased to 1.05 in 2017 Q3. Its down 0.21, from 1.26 in 2017Q2. It turned negative, as 11 investors sold BIOS shares while 32 reduced holdings. 17 funds opened positions while 28 raised stakes. 104.38 million shares or 0.59% more from 103.77 million shares in 2017Q2 were reported. Ameritas Investment Ptnrs holds 9,711 shares. Ardsley Advisory Prns stated it has 0.03% of its portfolio in BioScrip, Inc. (NASDAQ:BIOS). Us Bancorporation De has 0% invested in BioScrip, Inc. (NASDAQ:BIOS) for 49,244 shares. Price T Rowe Associates Md has invested 0% in BioScrip, Inc. (NASDAQ:BIOS). Art Advisors Lc has 68,254 shares. The New York-based Virtu Lc has invested 0% in BioScrip, Inc. (NASDAQ:BIOS). Natixis holds 15,569 shares. Fmr has invested 0% in BioScrip, Inc. (NASDAQ:BIOS). 5.12 million were reported by Vanguard. Bridgeway Mngmt Incorporated holds 319,900 shares or 0.01% of its portfolio. Goldman Sachs Gru invested in 61,910 shares. Invesco Limited has invested 0% in BioScrip, Inc. (NASDAQ:BIOS). Switzerland-based Credit Suisse Ag has invested 0% in BioScrip, Inc. (NASDAQ:BIOS). Amalgamated Commercial Bank reported 14,541 shares. Sei Invests has invested 0% in BioScrip, Inc. (NASDAQ:BIOS).

Among 38 analysts covering Alibaba (NYSE:BABA), 36 have Buy rating, 1 Sell and 1 Hold. Therefore 95% are positive. Alibaba had 168 analyst reports since August 12, 2015 according to SRatingsIntel. Bank of America maintained Alibaba Group Holding Limited (NYSE:BABA) rating on Monday, October 16. Bank of America has “Buy” rating and $200.0 target. Daiwa Securities maintained it with “Buy” rating and $125 target in Wednesday, September 28 report. The stock has “Buy” rating by Deutsche Bank on Thursday, September 29. The firm has “Buy” rating by Axiom Capital given on Monday, September 14. As per Friday, August 12, the company rating was maintained by Goldman Sachs. The stock of Alibaba Group Holding Limited (NYSE:BABA) has “Buy” rating given on Thursday, July 13 by Jefferies. The firm earned “Buy” rating on Wednesday, August 26 by M Partners. As per Monday, June 12, the company rating was maintained by Jefferies. The firm earned “Buy” rating on Monday, November 13 by Wells Fargo. The firm earned “Buy” rating on Friday, October 30 by M Partners.

Suvretta Capital Management Llc, which manages about $998.31 million and $3.54B US Long portfolio, upped its stake in Constellation Brands Inc (NYSE:STZ) by 101,490 shares to 1.78 million shares, valued at $354.82M in 2017Q3, according to the filing. It also increased its holding in Restaurant Brands Intl Inc by 415,540 shares in the quarter, for a total of 3.86M shares, and has risen its stake in F M C Corp (NYSE:FMC).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts